Abstract
Emerging global evidence points to country of origin as an important risk factor for developing gastric cancer (GC). Immigrants from high-incidence countries for GC may retain an increased risk despite living in low-incidence regions, and precursor lesions such as intestinal metaplasia may be more common in foreign-born individuals than in individuals born in the United States, particularly within high-risk racial/ethnic groups.1,2 Although the United States had 51 million immigrants in 2020—the highest number of foreign-born residents globally—data on the association between immigrant status and GC risk within the United States remain limited.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
